Speaker's Highlight

• Don Sin University of British Columbia, St. Paul Hospital (Canada)
  Kenneth R. Chapman Toronto General Hospital Research Institute (Canada)
• Parameswaran Nair McMaster University (Canada)
  Carolyn Calfee UCSF (U.S.A.)
• Gregory P. Downey University of Colorado School of Medicine (U.S.A.)
  David A. Schwartz University of Colorado School of Medicine (U.S.A.)
• Neil Schluger Tuberculosis Control Branch, California Department of Public Health (U.S.A.)
  Nick Kim Critical Care & Sleep Medicine, University of California San Diego (U.S.A.)
• Nicola Hananiah Baylor College of Medicine (U.S.A.)
  Jae-Joon Yim Seoul National University College of Medicine (Republic of Korea)
• Koichiro Asano Tokai University School of Medicine (Japan)
  Diahn-Warng Perng Taipei Veterans General Hospital (Taiwan)
• Konstantinos Kostikas University of Ioannina (Greece)
  Karin Klooster University Medical Center Groningen (Kingdom of the Netherlands)

• Spotting COPD Flare-Ups Early with Remote Monitoring

  For people living with chronic obstructive pulmonary disease, a sudden worsening of breathlessness, cough or sputum can quickly spiral into a hospital admission. Picking up these flare-ups before they take hold is a daily challenge for clinicians and patients alike. Remote monitoring offers a way to keep a continuous eye on lung health from the living room, the verandah or the back paddock, sending early warning signs straight to the care team.

  Across Australia, where distance, dust storms and bushfire smoke can complicate respiratory care, connected health tools are finding a real niche. Pairing home-based sensors with telehealth follow-up helps clinicians act before a cold turns into something far more serious, and it gives patients in regional and remote communities a fairer go at staying well.

  How Connected Monitoring Changes Daily Care

  Telemonitoring for COPD is built around simple, repeated measurements taken at home. A patient might use a Bluetooth spirometer to record daily forced expiratory volume, slip on a finger oximeter overnight, or wear a lightweight patch that tracks heart rate, respiratory rate and temperature. These readings flow into a smartphone app or a small hub device, then into a clinician dashboard that flags concerning trends.

  The value sits in pattern recognition rather than any single number. A drop in oxygen saturation over several mornings, a creeping rise in resting heart rate, or a fall in peak flow during a routine shower can all hint at an impending exacerbation. Algorithms compare the incoming stream against the patient's own baseline, so the alert feels personal rather than generic. When the system spots trouble, the practice nurse or respiratory specialist receives a nudge and can ring the patient, adjust medication, or recommend a same-day review.

  Why Australia Is a Natural Fit for This Approach

  Australia's geography shapes how respiratory medicine gets delivered. In places like Broken Hill, Cairns or Kalgoorlie, the nearest respiratory clinic can be a day's drive away, and the Royal Flying Doctor Service has long provided a safety net for those who cannot easily travel. Remote monitoring extends that logic: instead of flying a nurse out or asking a patient to push through a long trip, the data comes to the clinician.

  The health system has also moved to support this. Medicare-funded telehealth items, expanded during the pandemic, now cover routine respiratory reviews by video and phone. The Pharmaceutical Benefits Scheme subsidises the inhaled therapies and rescue packs used to treat flare-ups, and My Health Record allows uploaded oximetry trends and action plans to travel between the GP, the specialist and the hospital team. Add in the legacy of the 2019–20 bushfires, when smoke haze blanketed Sydney, Melbourne and Canberra for weeks and pushed hundreds of COPD patients into emergency departments, and the case for early home-based warning becomes hard to argue with.

  Reading the Signals That Matter

  Not every metric is equally useful. In Australian studies, peripheral oxygen saturation and self-reported breathfulness have come out as the strongest predictors of an oncoming exacerbation, especially when combined with a simple symptom diary. A patient who ticks "worse than yesterday" on a few evenings in a row, while overnight saturations drift from 94 percent to 90 percent, is showing a textbook pattern of viral or bacterial-driven decline.

  The technology is becoming more comfortable to live with. Modern pulse oximeters clip on like a small clothes peg, connected peak flow meters look like a slim torch, and adhesive biosensor patches sit behind the ear or on the chest for a week at a time. For older Australians who often worry about fiddly gadgets, devices have been deliberately pared back: a single button, a clear morning reading, and a text or app notification if something is off. Many kits run on the same charging cable as a phone, which helps when the local op-shop is the closest source of spare parts.

  What the Evidence Says About Outcomes

  Randomised trials across Europe, Asia and Australasia have consistently shown fewer unplanned hospital admissions and shorter stays when telemonitoring is layered onto usual care. An Australian multi-site study reported a roughly 30 percent reduction in exacerbation-related hospitalisations among high-risk patients using daily oximetry and symptom reporting, alongside a measurable drop in emergency department presentations.

  The benefits extend beyond the hospital. Patients describe feeling more in control of their condition, less anxious about sleeping alone, and more willing to seek help early because they trust the data behind the call. Carers, often a partner or an adult child, appreciate the reassurance of seeing a steady green light on the dashboard each morning. For practices working under tight Medicare schedules, the model also frees up face-to-face appointments for those who genuinely need hands-on assessment.

  Rolling It Out Without the Headaches

  Bringing telemonitoring into routine respiratory care in Australia takes a bit of planning. Reimbursement pathways for remote monitoring devices are still catching up with clinical guidelines, so funding often flows through hospital networks, research grants or integrated care programs rather than a single item number. Devices need to be matched to the patient: someone in suburban Parramatta with reliable NBN is a different prospect from a grazier on a station outside Longreach relying on a satellite hotspot.

  Training matters just as much as the hardware. Nurses, allied health staff and GPs benefit from short, practical sessions on how to triage alerts, when to call the patient, and how to document the review in My Health Record. Cultural fit is part of the picture too, with Aboriginal Community Controlled Health Organisations in the Northern Territory and Western Australia adapting the approach to local languages and community-led care models. Done well, telemonitoring slots into the existing web of GP, specialist, pharmacy and community health services, rather than sitting alongside it as a separate silo.

  What stays with you is the shift in mindset. Instead of waiting for the next emergency department visit, clinicians can act on the quiet warning signs that build over days, and patients can manage their condition with a steady flow of information rather than guesswork. For Australians living with COPD, especially those a long way from a major hospital, that early heads-up can be the difference between a quiet arvo at home and an unplanned flight to the city.

  Richard Russell Nuffield Department of Clinical Medicine, University of Oxford (United Kingdom)
• Mona Bafadhel King’s College London (United Kingdom)
  David Jackson Guy’s and St Thomas’ Hospital, King’s College London (United Kingdom)
• James Chalmers University of Dundee (United Kingdom)
  David Price University of Aberdeen (United Kingdom)